Bariatric Surgery Candidate clinical trials at University of California Health
3 in progress, 2 open to eligible people
Denosumab to Prevent High-Turnover Bone Loss After Bariatric Surgery
open to eligible people ages 25 years and up
Bariatric surgery leads to bone loss and increases fracture risk. This study evaluates whether denosumab can prevent the high-turnover bone loss that occurs after Roux-en-Y Gastric Bypass (RYGB) and sleeve gastrectomy (SG) surgery.
at UCSF
Multimodal Analgesia Effect on Post Surgical Patient
open to eligible females ages 35-65
Patients undergoing Bariatric Surgery at the University of California Davis Medical Center will be divided into two groups, one receiving Standard of Care pain control medications vs the second group which will receive non-narcotic pain medications with rescue pain medications available if needed
at UC Davis
Cognitive Impairment, Obesity, and the Effects of Bariatric Surgery
Sorry, accepting new patients by invitation only
Study is designed to screen psychological cognitive baseline and retention/improvement after weight loss surgery.
at UC Davis
Our lead scientists for Bariatric Surgery Candidate research studies include Anne Schafer, MD Victoria Lyo, MD.
Last updated: